CADTHCanadian Agency for Drugs and Technologies in Health (Ottawa, Ontario, Canada)
References in periodicals archive ?
To learn more about CADTH and the evidence we offer to help guide health care decisions in Canada, visit www.
2002 Discount rate CADTH 2006 Abbreviations: EQ5D, EuroQuol-5D, European quality of life-5 dimensions; MMR, mild mental retardation (IQ between 50 and 70); QALY, quality-adjusted life year; SEPPA, special education per pupil amount.
ca or please contact Stephanie Smith, CADTH Liaison Officer for New Brunswick, at 506-457-4948.
Created by the federal, provincial, and territorial governments, CADTH is an independent organization responsible for helping decision-makers across the country make the right decisions about how best to use drugs and other health technologies in our health care system.
The BMJ Clinical Evidence and CADTH filters contain some subject headings that are specific to drugs, such as "Drug Toxicity" and "Drug Hypersensitivity.
At CADTH, it is a common practice among information specialists to use the CADTH adverse filter only in combination with an observational filter so that randomized controlled trials and systematic reviews on a health technology would be searched without having a safety filter applied.
All publicly funded drug plans (except Quebec), cooperated to build, improve, and fund the CADTH Common Drug Review.
For example, right now, CADTH is reviewing drugs to manage chronic obstructive pulmonary disease, heart failure, ulcerative colitis, schizophrenia, vitreomacular adhesion, chronic migraine, Parkinson disease, growth hormone deficiency in adults and children, Turner Syndrome, and polyarticular juvenile idiopathic arthritis.
CADTH is an independent, not-for-profit agency funded by Canadian federal, provincial, and territorial governments to provide credible, impartial advice and evidence-based information about the effectiveness of drugs and other health technologies for the benefit of patients and for the sustainability of health care in Canada.
EDITOR'S NOTE: The following rebuttal received by the Chairs of the Diabetes Educator Section Chapters of New Brunswick, is in response to the article submitted by the Canadian Agency for Drugs and Technologies in Health (CADTH) entitled 'New CADTH Research Shows: Most People with Type 2 Diabetes Do Not Need to Test Their Blood Glucose as Often', Info Nursing, (Volume 41, Issue 1, Spring 2010)
Intended to appeal to a broad audience of CADTH stakeholders, these audio recordings or podcasts are designed to capture the highlights of an HTA report in less than ten minutes.